NCT00006519View on ClinicalTrials.gov

Capravirine to Treat Children With HIV Infection

PHASE1CompletedINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

October 31, 2004

Conditions

HIV Infection

Interventions

DRUG

Capravirine

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00006519 - Capravirine to Treat Children With HIV Infection | Biotech Hunter | Biotech Hunter